Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

JAAA vs XBI: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, JAAA returned +4.7% to XBI's +41.2%, and JAAA charges 0.20% to XBI's 0.35%.

askIQ about this page

askIQ about JAAA and XBI

Net assets: $32.5bn on Oct 28, 2026 for Janus Henderson AAA CLO ETF, and $10.3bn on Oct 27, 2026 for State Street SPDR S&P Biotech ETF.

At a glance
+4.7%
JAAA total return, 1 year
+41.2%
XBI total return, 1 year
0.20%
JAAA expense ratio
0.35%
XBI expense ratio

Pair scorecard

JAAA costs 0.15 points a year less; their one-year returns differ by 36.5 points; JAAA is 3.2 times larger.

JAAA vs XBI: Differences, Returns & Fees
MeasureJAAAXBI
Return
Total return, 1 year+4.7%+41.2%
Drawdown
Below its all-time high8.9%, high on Feb 8, 2021
Benchmark
What it tracksNo index, actively managedBiotech
Cost and size
Expense ratio0.20%0.35%
Net assets, as of Oct 27, 2026$32.5bn$10.3bn
Active share vs the S&P 50098%
Holdings
Holdings in common0%
In the S&P 500, by weight13%
Top ten holdings, share of the fund18%

Holdings in common uses holdings dated Jul 31, 2026 and Oct 27, 2026. Method

What they share

0%

By the books each fund has filed, JAAA and XBI hold 0% of their money in the same securities at the same weight. Holdings dated Jul 31, 2026 and Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first JAAA XBI
Only in one fund ↓
Only in JAAA
KKR CLO 35 Ltd. 0.85%
AB BSL CLO 1 Ltd. 0.79%
Anchorage Capital CLO 16 Ltd. 0.73%
Palmer Square CLO Ltd. 0.69%
Ares LXI CLO Ltd. 0.68%
Carlyle US CLO Ltd. 0.62%
WISE CLO Ltd. 0.62%
Carlyle US CLO Ltd. 0.60%
Only in XBI
MODERNA INC 2.24%
TWIST BIOSCIENCE CORP 1.86%
NATERA INC 1.82%
BIOGEN INC 1.75%
HALOZYME THERAPEUTICS INC 1.75%
UNITED THERAPEUTICS CORP 1.71%
AMGEN INC 1.68%
ABBVIE INC 1.67%
Check overlap with more funds →

Side by side

JAAA Janus Henderson AAA CLO ETF XBI State Street SPDR S&P Biotech ETF
Where it sits Bond ETF Thematic ETF
What it is Actively managed Biotech
Total return, 1 year +4.7% +41.2%
Expense ratio 0.20% 0.35%
Holdings 598 165
Net assets, JAAA as of Oct 28, 2026 and XBI as of Oct 27, 2026 $32.5bn $10.3bn

JAAA and XBI on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

XBI flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
JAAA

JAAA is actively managed and tracks no index. Over the year to Oct 28, 2026 it returned +4.7% with distributions reinvested. The prospectus expense ratio is 0.20% a year.

XBI

By weight, 13% of XBI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 18% of the fund across 165 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +41.2% with distributions reinvested. It sits 8.9% below its all-time high of Feb 8, 2021.

Questions people ask

Are JAAA and XBI in the same category?
JAAA is a bond ETF and XBI is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, JAAA or XBI?
In the year to Oct 28, 2026, with distributions reinvested, JAAA returned +4.7% and XBI +41.2%.
Which is cheaper, JAAA or XBI?
JAAA is cheaper, by 0.15 percentage points a year. That is about $15 on $10,000 held for a year. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, JAAA against XBI, data as of Oct 28, 2026. https://etfiq.com/compare/any/jaaa-vs-xbi

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.